Navigation Links
Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
Date:5/15/2008

- Unprecedented amount of research reflects depth and breadth of collaboration with investigators worldwide to develop new treatments for

diverse forms of cancer

- Plenary session to highlight impact of Zometa(R), the leading IV bisphosphonate, on relapse rate of patients with early-stage breast cancer - Four oral sessions to feature RAD001, first oral once-daily continuous inhibitor of mTOR, including first results of RECORD-1 study in renal cell

carcinoma

- Updated Phase II results with Tasigna(R) in Philadelphia

chromosome-positive chronic myeloid leukemia to be presented

EAST HANOVER, N.J., May 15 /PRNewswire/ -- Novartis Oncology announced today that the 44th annual meeting of the American Society of Clinical Oncology (ASCO) will include an unprecedented amount of research drawing from Novartis Oncology's robust pipeline of investigational compounds and existing cancer therapies. Novartis Oncology's cancer therapies will be the subject of more than 170 abstracts at the meeting, and will be highlighted in a plenary session, as well as seven oral presentations.

A plenary session will feature the first efficacy results from the ABCSG-12 study, looking at the impact of Zometa(R) (zoledronic acid) on disease-free survival in patients with early-stage breast cancer (Abstract #LBA4: Sunday, June 1, 2008; 1:45 PM to 2:00 PM CDT). In addition, late-breaking data on the role of RAD001 (everolimus) as a potential new treatment option for patients with advanced kidney cancer who have failed standard therapies will be presented in an oral session (Abstract #LBA5026: Saturday, May 31, 2008; 4:30 PM-4:45 PM CDT).

"This is a particularly exciting year for Novartis Oncology in advancing research and touching the lives of thousands of cancer patients," said David Epstein, CEO & President of Novartis Oncology. "Our scientific presence at ASCO shows that N
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
2. Spirit II Results Support Strength of Boston Scientifics Two Drug-Eluting Stent Platforms
3. BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB
4. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
5. Major Deficiencies in Design; Funding of Clinical Trials Affects Future of Scientific Innovation
6. Inverness Medical Innovations to Present at CIBC World Markets 18th Annual Healthcare Conference on November 7, 2007
7. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
8. OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) is Subject of Sessions on Innovation at TCT 2007
9. StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014 Research and ... Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market ... For the purposes of this report, the human microbiome ... The human microbiome market is expected to be valued ... at a CAGR of 22.3% within the forecast period of ...
(Date:9/19/2014)... Sept. 19, 2014  Diplomat, the nation,s largest independent ... Dreyer to the Board of Directors on September ... will also serve as chair of the Audit Committee. ... of accounting, financial, compliance and operating experience in the ... served as chief financial officer, chief operating officer and ...
(Date:9/19/2014)... Larry J. Merlo , President and CEO ... before the National Press Club in Washington, D.C. ... to stop selling tobacco products and its leadership in driving ... "Dramatic changes in our health care system pose enormous ... has said. "CVS Health has a truly unique combination of ...
Breaking Medicine Technology:Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 2Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 3David Dreyer Appointed to Diplomat Board of Directors 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3
... (Nasdaq: PRGO; TASE) today announced that it has signed ... assets of Paddock Laboratories, Inc. ("Paddock"), a privately-held, Minneapolis-based ... $540 million in cash. Perrigo expects to receive a ... of Paddock,s assets. The net present value of this ...
... MIAMI, Jan. 20, 2011 CyberKnife Center of ... Schwade, MD, FACR, FACRO, FASTRO, announces a presentation ... 38th Annual Caribbean Association of Neurosurgeon,s Annual Meeting, ... (Photo: http://photos.prnewswire.com/prnh/20110120/FL32893 ) ...
Cached Medicine Technology:Perrigo to Acquire Assets of Paddock Labs for $540 Million 2Perrigo to Acquire Assets of Paddock Labs for $540 Million 3Perrigo to Acquire Assets of Paddock Labs for $540 Million 4Perrigo to Acquire Assets of Paddock Labs for $540 Million 5CyberKnife Center of Miami to Present at 38th Annual Caribbean Association of Neurosurgeon's Conference 2
(Date:9/19/2014)... News) -- U.S. military troops deployed to sunny climates ... to a new study. Many returning troops ... some cases, military personnel developed blisters on their skin ... size of their moles since being deployed overseas. ... skin cancer, the study authors noted. "The past ...
(Date:9/19/2014)... News) -- Pregnant women who live in leafy, green neighborhoods ... babies, a new study suggests. Researchers analyzed data from ... expectant mothers who lived in a neighborhood with plenty of ... risk of very preterm birth (before 30 weeks) and a ... 36 weeks). Babies born to mothers who lived in ...
(Date:9/19/2014)... The U.S. Food and Drug Administration approved a new type ... a class of once-a-week injectable drugs that help manage blood ... "Trulicity is a new treatment option, which can be used ... sugar levels in the overall management of type 2 diabetes," ... Drug Evaluation II, said in an agency news release. ...
(Date:9/19/2014)... 2014 The Alliance for Bangladesh ... the National Fire Protection Association (NFPA), a recognized ... today in a Memorandum of Understanding signed by ... and other stakeholders with information, guidance and access ... health and safety of workers in ready-made garment ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 MetroMD, a leading ... the “God Particle” of human health. This therapy has grown ... making the therapy more effective, safe and dependable. It has ... them an opportunity to live a very healthy and active ... concept of HGH therapy, a senior therapist at MetroMD said, ...
Breaking Medicine News(10 mins):Health News:Some U.S. Troops May Face Greater Skin Cancer Risk 2Health News:Do Greener Neighborhoods Produce Healthier Babies? 2Health News:FDA Approves Another Weekly Injectable Drug for Type 2 Diabetes 2Health News:Alliance for Bangladesh Worker Safety and NFPA Sign Memorandum of Understanding to Strengthen Safety in Bangladesh Garment Factories 2Health News:Alliance for Bangladesh Worker Safety and NFPA Sign Memorandum of Understanding to Strengthen Safety in Bangladesh Garment Factories 3Health News:MetroMD Announces Better HGH Therapy - the ‘God Particle’ of Human Health 2
... , FRIDAY, July 15 (HealthDay News) -- In an attempt ... of governments have raised taxes on cigarettes, yet many people ... Canadian study. But the public health measure has prompted ... researchers recently reported in the International Journal of Environmental ...
... In a study, Identification of unrecognized diabetes and pre-diabetes ... issue of the Journal of Dental Research, ... that dental visits represented a chance to intervene in ... pre-diabetes who are unaware of their condition. The study ...
... sizes usually mean we eat more food, but according to ... bigger bites lead to eating lessin restaurant settings. "In ... bite-sizes on overall quantity of food consumed," write authors Arul ... Utah, Salt Lake City). The authors conducted a field ...
... HealthDay Reporter , THURSDAY, July 14 (HealthDay News) -- ... the immune system,s response to HIV, the AIDS virus, in ... a vaccine. The findings won,t have an immediate big ... do reveal how soldiers of the immune system known as ...
... five to ten percent of patients with primary ... such as headaches, seizures, confusion, difficulty swallowing and ... life-threatening form of brain invasion from cancer called ... University of California, San Diego School of Medicine ...
... This release is available in German . ... Max Planck Institute for Dynamics and Self-Organization (Gttingen, Germany), ... de Lyon (France), the University Medicine Gttingen (Germany), the ... de Nice (France) have developed a new low-energy method ...
Cached Medicine News:Health News:Cigarette Tax Unlikely to Deter Some Smokers: Report 2Health News:Dentists can identify people with undiagnosed diabetes, Columbia researchers show 2Health News:Size matters: Why do people eat less when they have big forks? 2Health News:Antibody Finding Might Help in Search for HIV Vaccine 2Health News:Novel combined therapy extends life, diminishes pain in brain cancer patients 2Health News:A 'LEAP' in controlling cardiac fibrillation 2Health News:A 'LEAP' in controlling cardiac fibrillation 3
... are part of the Freedom Urinary ... leg bags, kits, and accessories designed ... our customers. These leg bags are ... of 100% latex-free soft, textured medical ...
... are part of the Freedom Urinary ... leg bags, kits, and accessories designed ... our customers. These leg bags are ... of 100% latex-free soft, textured medical ...
The latex-free, PVC-free Antibacterial Hydro Personal catheter combines two remarkable innovations into one exclusive catheter that delivers an antibacterial agent while providing the virtually frict...
The latex-free, PVC-free Antibacterial Hydro Personal catheter combines two remarkable innovations into one exclusive catheter that delivers an antibacterial agent while providing the virtually frict...
Medicine Products: